ZACKS
Search documents
Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Tops Revenue Estimates
ZACKS· 2026-02-19 23:21
Core Viewpoint - Tandem Diabetes Care, Inc. reported a quarterly loss of $0.01 per share, outperforming the Zacks Consensus Estimate of a loss of $0.05, marking an earnings surprise of +80.51% compared to a loss of $0.44 per share a year ago [1][2] Financial Performance - The company posted revenues of $290.38 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 5.21% and showing an increase from $252.45 million in the same quarter last year [2] - Over the last four quarters, Tandem Diabetes Care has surpassed consensus revenue estimates four times [2] Stock Performance - Shares of Tandem Diabetes Care have declined approximately 13.8% since the beginning of the year, while the S&P 500 has gained 0.5% [3] - The current Zacks Rank for the stock is 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.45 on revenues of $249.96 million, and for the current fiscal year, it is -$0.99 on revenues of $1.1 billion [7] - The trend of earnings estimate revisions is mixed ahead of the earnings release, which could influence future stock performance [6] Industry Context - The Medical - Instruments industry, to which Tandem Diabetes Care belongs, is currently ranked in the top 32% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]
Extra Space Storage (EXR) Q4 FFO and Revenues Surpass Estimates
ZACKS· 2026-02-19 23:21
Core Viewpoint - Extra Space Storage (EXR) reported quarterly funds from operations (FFO) of $2.08 per share, exceeding the Zacks Consensus Estimate of $2.03 per share, and showing an increase from $2.03 per share a year ago [1][2] Financial Performance - The FFO surprise for the quarter was +2.29%, with the company surpassing consensus FFO estimates three times over the last four quarters [2] - Revenues for the quarter ended December 2025 were $857.47 million, surpassing the Zacks Consensus Estimate by 0.76%, compared to $821.9 million in the same quarter last year [3] Stock Performance - Extra Space Storage shares have increased by approximately 11.5% since the beginning of the year, while the S&P 500 has gained 0.5% [4] Future Outlook - The current consensus FFO estimate for the upcoming quarter is $2.02 on revenues of $849.89 million, and for the current fiscal year, it is $8.25 on revenues of $3.44 billion [8] - The estimate revisions trend for Extra Space Storage was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [7] Industry Context - The REIT and Equity Trust - Other industry is currently ranked in the bottom 32% of over 250 Zacks industries, suggesting that the outlook for the industry can significantly impact stock performance [9]
Akamai Technologies (AKAM) Beats Q4 Earnings and Revenue Estimates
ZACKS· 2026-02-19 23:16
Akamai Technologies (AKAM) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.66 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +5.01%. A quarter ago, it was expected that this cloud services provider would post earnings of $1.64 per share when it actually produced earnings of $1.86, delivering a surprise of +13.41%.Over the last four q ...
Rimini Street (RMNI) Lags Q4 Earnings Estimates
ZACKS· 2026-02-19 23:16
Rimini Street (RMNI) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -17.65%. A quarter ago, it was expected that this company would post earnings of $0.1 per share when it actually produced earnings of $0.08, delivering a surprise of -20%.Over the last four quarters, the company has ...
Live Nation (LYV) Reports Q4 Loss, Beats Revenue Estimates
ZACKS· 2026-02-19 23:16
Live Nation (LYV) came out with a quarterly loss of $1.06 per share versus the Zacks Consensus Estimate of a loss of $1.08. This compares to earnings of $0.56 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +2.20%. A quarter ago, it was expected that this ticket seller and concert promoter would post earnings of $1.21 per share when it actually produced earnings of $0.73, delivering a surprise of -39.67%.Over the last four qua ...
Texas Roadhouse (TXRH) Misses Q4 Earnings and Revenue Estimates
ZACKS· 2026-02-19 23:16
Texas Roadhouse (TXRH) came out with quarterly earnings of $1.28 per share, missing the Zacks Consensus Estimate of $1.53 per share. This compares to earnings of $1.73 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -16.50%. A quarter ago, it was expected that this restaurant chain would post earnings of $1.28 per share when it actually produced earnings of $1.25, delivering a surprise of -2.34%.Over the last four quarters, th ...
Sprouts Farmers (SFM) Surpasses Q4 Earnings Estimates
ZACKS· 2026-02-19 23:16
Sprouts Farmers (SFM) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.79 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.66%. A quarter ago, it was expected that this natural and organic food retailer would post earnings of $1.17 per share when it actually produced earnings of $1.22, delivering a surprise of +4.27%.Over the last fo ...
Ouster, Inc. (OUST) Gains As Market Dips: What You Should Know
ZACKS· 2026-02-19 23:15
Ouster, Inc. (OUST) closed at $19.08 in the latest trading session, marking a +2.64% move from the prior day. This change outpaced the S&P 500's 0.28% loss on the day. Elsewhere, the Dow lost 0.54%, while the tech-heavy Nasdaq lost 0.31%. Prior to today's trading, shares of the company had lost 26.49% lagged the Computer and Technology sector's loss of 3.36% and the S&P 500's loss of 0.76%.The upcoming earnings release of Ouster, Inc. will be of great interest to investors. The company's earnings report is ...
LegalZoom (LZ) Q4 Earnings Lag Estimates
ZACKS· 2026-02-19 23:10
分组1 - LegalZoom reported quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share, and down from $0.19 per share a year ago, representing an earnings surprise of -7.61% [1] - The company posted revenues of $190.27 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 3.22%, compared to year-ago revenues of $161.71 million [2] - LegalZoom shares have declined approximately 29.8% since the beginning of the year, while the S&P 500 has gained 0.5% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $0.16 on revenues of $201.35 million, and for the current fiscal year, it is $0.74 on revenues of $802.25 million [7] - The Zacks Industry Rank indicates that the Industrial Services sector is currently in the bottom 32% of over 250 Zacks industries, suggesting that the outlook for the industry can significantly impact stock performance [8]
Travere Therapeutics (TVTX) Matches Q4 Earnings Estimates
ZACKS· 2026-02-19 23:10
分组1 - Travere Therapeutics reported quarterly earnings of $0.03 per share, aligning with the Zacks Consensus Estimate, compared to a loss of $0.73 per share a year ago, representing an earnings surprise of +16.73% [1] - The company posted revenues of $129.69 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 8.97%, and this is an increase from year-ago revenues of $74.79 million [2] - Travere has surpassed consensus EPS estimates four times over the last four quarters and topped consensus revenue estimates three times during the same period [2] 分组2 - The stock has underperformed, losing about 27.1% since the beginning of the year, while the S&P 500 has gained 0.5% [3] - The current consensus EPS estimate for the coming quarter is -$0.07 on $135 million in revenues, and for the current fiscal year, it is $0.62 on $673.01 million in revenues [7] - The Zacks Industry Rank for Medical - Biomedical and Genetics is in the top 36% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]